Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-27 11:35 am Purchase | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | Lamond David | 2,048,938 6.900% | 93,773 (+4.80%) | Filing History |
| 2021-03-25 4:17 pm Sale | 2021-03-16 | 13G | Quince Therapeutics, Inc. QNCX | PFIZER INC PFE | 2,056,377 7.000% | -86,995 (-4.06%) | Filing History |
| 2021-03-10 2:10 pm Purchase | 2021-03-10 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 3,170,731 10.700% | 560,494 (+21.47%) | Filing History |
| 2021-02-16 2:24 pm Unchanged | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,580,455 8.700% | 0 (Unchanged) | Filing History |
| 2021-02-16 1:57 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,580,455 8.700% | 2,580,455 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital Research Global Investors | 2,605,753 8.800% | 162,839 (+6.67%) | Filing History |
| 2021-02-16 12:34 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 2,610,237 8.800% | 2,610,237 (New Position) | Filing History |
| 2021-02-12 5:37 pm Sale | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | PFIZER INC PFE | 2,143,372 7.300% | -1,106,601 (-34.05%) | Filing History |
| 2021-02-01 4:25 pm Purchase | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | EPQ LLC CTYM PS | 2,863,096 9.710% | 36,300 (+1.28%) | Filing History |
| 2021-01-28 5:57 pm Sale | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | TAKEDA PHARMACEUTICAL CO LTD | 87,258 0.300% | -2,592,544 (-96.74%) | Filing History |